Literature DB >> 27450899

An LC/MS/MS method for the simultaneous determination of individual sphingolipid species in B cells.

Si Mi1, Yuan-Yuan Zhao1, Rebecca F Dielschneider2, Spencer B Gibson2, Jonathan M Curtis3.   

Abstract

Comprehensive profiling of sphingolipids is of great importance for clinical and pharmaceutical studies. An LC/MS/MS method was established for the simultaneous separation and quantification of individual sphingolipid species including ceramides, dihydroceramides, glucosylceramides, sphingosine, sphingosine-1-phosphate, sphinganine and sphinganine-1-phosphate. All target individual sphingolipid species were separated and quantified in a single chromatographic run of <20min. Method validation results indicated that calibration curves were linear in the range of 2.5-10,000nM for ceramides and glucosylceramides, 10-10,000nM for dihydroceramides, 5-10,000nM for sphingosine, sphingosine-1-phosphate, sphinganine and sphinganine-1-phosphate, respectively. The limits of detection ranged from 0.5nM to 5nM. Accuracies of 92.5-113% with precisions of 0.3-8.0% RSD were obtained for all of the standards over a wide range of concentrations. The application of this method was demonstrated using B cells collected from Chronic Lymphocytic Leukemia patients (n=5) and healthy donors (n=4). 17 sphingolipid species were successfully characterized and quantified in the lipid extract. This is a rapid method that could be readily adapted to lipidomic investigations of sphingolipids in other bio-fluids and tissues.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cells; Chronic Lymphocytic Leukemia; LC/MS/MS; Quantification; Sphingolipids; Validation

Mesh:

Substances:

Year:  2016        PMID: 27450899     DOI: 10.1016/j.jchromb.2016.07.028

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Sphingolipid metabolism in type 2 diabetes and associated cardiovascular complications.

Authors:  Jing Sui; Mingqian He; Yue Wang; Xinrui Zhao; Yizhi He; Bingyin Shi
Journal:  Exp Ther Med       Date:  2019-09-06       Impact factor: 2.447

2.  "Fix and Click" for Assay of Sphingolipid Signaling in Single Primary Human Intestinal Epithelial Cells.

Authors:  Luke A Gallion; Yuli Wang; Angelo Massaro; Ming Yao; Brae V Petersen; Quanzheng Zhang; Weigang Huang; Adam J Carr; Qisheng Zhang; Nancy L Allbritton
Journal:  Anal Chem       Date:  2022-01-12       Impact factor: 6.986

3.  Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy.

Authors:  Claudia Rossi; Ilaria Cicalini; Mirco Zucchelli; Maria di Ioia; Marco Onofrj; Luca Federici; Piero Del Boccio; Damiana Pieragostino
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

4.  A Metabolomics Approach Reveals Immunomodulatory Effects of Proteinaceous Molecules Derived From Gut Bacteria Over Human Peripheral Blood Mononuclear Cells.

Authors:  Noelia Cambeiro-Pérez; Claudio Hidalgo-Cantabrana; Marco A Moro-García; Rebeca Alonso-Arias; Jesús Simal-Gándara; Borja Sánchez; Elena Martínez-Carballo
Journal:  Front Microbiol       Date:  2018-11-13       Impact factor: 5.640

5.  Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry.

Authors:  Dominik Wigger; Erich Gulbins; Burkhard Kleuser; Fabian Schumacher
Journal:  Front Cell Dev Biol       Date:  2019-10-01

6.  Strong Alterations in the Sphingolipid Profile of Chickens Fed a Dose of Fumonisins Considered Safe.

Authors:  Didier Tardieu; Maria Matard-Mann; Pi Nyvall Collén; Philippe Guerre
Journal:  Toxins (Basel)       Date:  2021-10-30       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.